Skip to content
value.today
Total raised
$20 M
3 rounds on record
Latest round
$10 M
Sep 2017
First round on record
Oct 2012
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Mitralign Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2017$10 MNo. 3$2 to $10 million

Mitralign Inc: Raise no. 3, Sep 2017

Investors in this round

19 investors had bought by the notice of Feb 20, 2018: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $30 M offered; $20 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Lisa P. Mastromattei · Executive Officer
  • Lisa P. Wipperman Heine · Executive Officer
  • Richard P. Geoffrion · Executive Officer, Director
  • Aditya P. Puri · Director
  • Carolyn P. Bates · Director
  • Daniel P. Cole · Director
  • Martien P. Van Osch · Director
  • Yuval P. Binur · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Richard P. Geoffrion, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 20, 2018. Read the notice at the SEC.

equitySEC
Jun 2014$8 MNo. 2$2 to $10 million

Mitralign Inc: Raise no. 2, Jun 2014

Investors in this round

12 investors had bought by the notice of Jun 20, 2014: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard P. Geoffrion · Executive Officer, Director
  • Sophia P. Wong · Executive Officer
  • Yuval P. Binur · Executive Officer, Director
  • Carolyn P. Bates · Director
  • Daniel P. Cole · Director
  • Daniel P. Lemaitre · Director
  • Martien P. Van Osch · Director
  • Zi P. Zhenjun · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Amount Sold in Item 13 and number of investors in Item 14 include sales to 3 non-US investors”

Signed by Richard P. Geoffrion, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 20, 2014. Read the notice at the SEC.

equitySEC
Oct 2012$2 MNo. 1Under $2 million

Mitralign Inc: Raise no. 1, Oct 2012

Investors in this round

9 investors had bought by the notice of Oct 29, 2012: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$50,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$130,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Richard P. Geoffrion · Executive Officer, Director
  • Carolyn P. Bates · Director
  • Daniel P. Cole · Director
  • Martien P. van Osch · Director
  • Yuval P. Binur · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Forefront Capital Markets LLC (CRD 151812) · New York, New YorkSold in CA, CO, MO, NY, TN

Signed by Richard P. Geoffrion, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 29, 2012. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Mitralign Inc chose not to state its revenue in its newest notice of a funding round (Feb 2018).

    SEC Form D · Feb 2018

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Feb 2018

That is all the official record says: Mitralign Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Mitralign Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Mitralign Inc
NameRoleNamed in
Lisa P. MastromatteiExecutive officerFeb 2018
Lisa P. Wipperman HeineExecutive officerFeb 2018
Richard P. GeoffrionExecutive officerFeb 2018
Sophia P. WongExecutive officerJun 2014
Yuval P. BinurExecutive officerJun 2014
Aditya P. PuriDirectorFeb 2018
Carolyn P. BatesDirectorFeb 2018
Daniel P. ColeDirectorFeb 2018
Martien P. Van OschDirectorFeb 2018
Richard P. GeoffrionDirectorFeb 2018
Yuval P. BinurDirectorFeb 2018
Daniel P. LemaitreDirectorJun 2014
Zi P. ZhenjunDirectorJun 2014
Martien P. van OschDirectorOct 2012